Chemicals were selected based on IARC cancer classifications, including those known to cause breast cancer in humans (IARC 2014b), those with less than sufficient human evidence of breast cancer, known carcinogens without evidence of causing breast cancer, and well-studied chemicals that have no evidence of carcinogenicity (IARC 2014a).
Arsenite (iAsIII) can promote mutagenicity and carcinogenicity of other carcinogens.
These models express the relationship between a certain chemical property (e.g. fragment) and the effect (e.g. carcinogenicity) in a qualitative way (carcinogenic or noncarcinogenic), without assigning a continuous numerical value to the toxicity, such as a specific quantitative dose, which can have a wide range of values.
Government agencies, drug companies, and the chemical industry should conduct and compare the results of 2-year bioassays of known carcinogens or chemicals for which there is equivocal evidence of carcinogenicity with longer-term studies, with and without in utero exposure.
US National Toxicology Program, part of the National Institutes of Health, has classified BHA as "reasonably anticipated to be a human carcinogen" based on evidence of carcinogenicity in animal studies.
The Working Group specifically noted the following: 1) there was sufficient evidence in humans and experimental animals for the carcinogenicity of betel quid with and without tobacco; 2) there was sufficient evidence in experimental animals for the carcinogenicity of areca nut, and 3) there was evidence suggesting lack of carcinogenicity in experimental animals for betel leaf and slaked lime [ 2].
Huff (2002) evaluated bioassay results for 14 chemicals studied by both the RI and NTP and reported consistent carcinogenicity conclusions for 11 chemicals, 9 with carcinogenic activity and 2 without.
This paper explores our present understanding of carcinogenicity and the mechanisms underlying the carcinogenic response.
Without a way to anticipate the carcinogenicity of complex mixtures, an important gap in capability exists and it creates a significant weakness in current risk assessment practices.
Pb is a "possible human carcinogen" because of inconclusive evidence of human carcinogenicity and sufficient evidence of animal carcinogenicity.
